Read this #commentary about home modifications to reduce disability in older adults with functional disability
Home Modifications to Reduce Disability in Vulnerable Older Adults
Functional disability, as marked by the inability to perform tasks needed to live independently, becomes increasingly common with advancing age and is...
Original Article: Decolonization to Reduce Postdischarge Infection Risk among #MRSA Carriers https://t.co/Efy5OJG0hG
Read this editor’s note on anticoagulation therapy in non–ST-segment elevation acute coronary syndrome
Anticoagulation in Non–ST-Segment Elevation Acute Coronary Syndrome
Non–ST-segment elevation acute coronary syndrome (NSTE-ACS) affects over 500 000 patients in the United States each year. This condition spans a c...
“The major implication of this meta-analysis is to highlight that an acute concussion might add to long-term neuropsychiatric illness.” Read more in this #editorial
On the Link Between Concussions and Suicide
Tiaina Baul (“Junior”) Seau was born on January 12, 1969, graduated from high school in 1987, and attended college until drafted by the National F...
New @JAMAInternalMed study: CAPABLE (@JHUNursing 's program to help seniors #AgeInPlace) reduced disability in #LowIncome #OlderAdults by 30% https://t.co/hyNIBWO0G4
Half a million new cases of #cervicalcancer are added each year; 85% occur in low‐resource regions or among those from socioeconomically weaker sections of society. For more info see our most downloaded paper of 2018: Cancer of the cervix uteri https://t.co/mVtYoFN2zV #openaccess
The SPRINT MIND trial was designed as part of SPRINT, with all-cause adjudicated probable dementia as a primary outcome and MCI and a composite measure of any cognitive impairment (probable dementia or MCI) as secondary outcomes. https://t.co/De8l5eZPfi
Permanent Ink: Forging connections with patients through conversations about their tattoos. https://t.co/jnhnHBfkO1
Editorial: Combination Therapy as First-Line Treatment in Metastatic Renal-Cell Carcinoma https://t.co/pC2fkdnT5s #GU19
Among 886 patients with advanced renal-cell cancer, median progression-free survival was 13.8 months among those assigned to avelumab plus axitinib and 7.2 months among those assigned to sunitinib. Toxic effects of grade 3 or higher were similar in the two groups. #GU19
KEYNOTE-426: Among patients with untreated advanced renal-cell carcinoma, treatment with pembrolizumab plus axitinib resulted in significantly longer overall survival and progression-free survival, as well as a higher objective response rate, than treatment with sunitinib. #GU19
The Waverly Gallery is a reminder that with dementia, as with all progressive disease, the family is the patient; decline spreads like tau protein through the play's relationships, leading to short-circuiting and dysfunction of family connections. https://t.co/K3gT6A0NDA
The severity of impairments across domains of nonsocial and social cognition in adults with autism spectrum disorder identified highlight key intervention targets and suggest significant implications for clinical practice. https://t.co/oHRs0D7LNe
In this US-based #cancer #epidemiology study, use of active surveillance and watchful waiting for men with low-risk localized #prostatecancer increased between 2010 and 2015, becoming the most common management approach. https://t.co/gKue0SlF6r
Clinical Pearls & Morning Reports: A Woman with Delusional Thinking and Paresthesia https://t.co/XS7iMzvzzM via @NEJMres360
Editorial: Genetic Susceptibility to Alopecia https://t.co/5wVs55tU8n